PALM HARBOR, Fla. -- K.J. Choi was named this week’s AstraZeneca Charity Challenge winner for his first-place standing entering the final round of the Chrysler Championship. Choi used a nine-foot birdie on the 18th hole to take a one-stroke over three players into Sunday’s final round of the Chrysler Championship. The AstraZeneca Charity Challenge, formerly known as the CRESTOR® Charity Challenge, is a season-long competition that recognizes and rewards the tournament leader entering the final round at 35 PGA TOUR events. Through the sponsorship, AstraZeneca will donate $3.5 million this year to designated health care charities and will have donated a three-year total of $9.7 million by the conclusion of the 2006 PGA TOUR season.

For Choi’s performance, AstraZeneca will donate $50,000 to CancerCare and $50,000 to the Susan G. Komen Breast Cancer Foundation, on behalf of Choi and the Chrysler Championship. October is National Breast Cancer Awareness Month, and all AstraZeneca Charity Challenge beneficiaries during the month of October will be cancer-related.

“CancerCare is grateful to AstraZeneca for its ongoing commitment to CancerCare and its free support services for people affected by cancer,” said Diane Blum, executive director, CancerCare. “This generous donation, given through the AstraZeneca Charity Challenge, will help to provide vital information and resources to thousands of individuals who are affected by this disease.”

“Monies received by the Komen Foundation go directly to support our fight against breast cancer, funding ground breaking research around the world and education, screening and treatment programs in more than 18,000 communities,” said Cindy Schneible, vice president of resource development for the Komen Foundation. “Thanks to the support of generous donors and volunteers, every advance in breast cancer has been touched in some way by a Komen grant. Together, we are saving lives and working to create a world without breast cancer.”

AstraZeneca produces a wide range of products that make significant contributions to treatment options and patient care including CRESTOR, NEXIUM, SEROQUEL, ARIMIDEX, and PULMICORT RESPULES. Through this year’s sponsorship, as part of its commitment to patient health and well being, AstraZeneca will also designate health care related charities across therapeutic areas as recipients at the 35 PGA TOUR events throughout the year.

“AstraZeneca’s partnership with the PGA TOUR is an integral part of our mission of giving back in local communities throughout America,” said Tony Zook, CEO, AstraZeneca U.S. “The AstraZeneca Charity Challenge offers a unique platform for providing important disease awareness, health information and education to make a difference in the lives of patients and consumers everyday.”

The AstraZeneca Charity Challenge is the centerpiece of a multi-year PGA TOUR partnership with AstraZeneca (NYSE:AZN). Last year, AstraZeneca donated $3.5 million through the program. Highlights from the AZCC include:

• Last week the AstraZeneca Charity Challenge winner at the FUNAI Classic at the Walt Disney World Resort was Troy Matteson. This was Matteson’s second consecutive AstraZeneca Charity Challenge victory

• At 25 of the 33 tournaments of 2006, the AstraZeneca Charity Challenge winner or co-winner went on to win the tournament

• More than 100 charities have benefited from the program

• Vijay Singh leads all players with 10 AstraZeneca Charity Challenge wins. With some of his charitable “winnings,” Singh donated money to the American Red Cross Hurricane Relief Funds in Florida and New Orleans

• Other multiple winners have included Jim Furyk, Tom Lehman, Phil Mickelson and Rod Pampling (four), Stuart Appleby, Chad Campbell, Ben Curtis, Luke Donald, Sergio Garcia, Carl Petterson, Adam Scott, David Toms and Tiger Woods (three), and the following players who triumphed twice: Billy Andrade, Bart Bryant, Chris Couch, Chris DiMarco, Tim Herron, Zach Johnson, Troy Matteson, Arron Oberholser, Joe Ogilvie, Kenny Perry and Ted Purdy

Fans can log on to www.astrazeneca.pgatour.com to read about past AstraZeneca Charity Challenge winners and learn more about AstraZeneca.

About CancerCare

CancerCare is a national non-profit organization that provides free professional support services to anyone affected by cancer: people with cancer, caregivers, children, loved ones, and the bereaved. CancerCare programs—including counseling, education, financial assistance and practical help—are provided by trained oncology social workers and are completely free of charge. Founded in 1944, CancerCare now provides individual help to more than 90,000 people each year, in addition to the more than one million people who gain information and resources from its website. Find out more about CancerCare by calling 1-800-813-HOPE (4673) or at www.cancercare.org.

About the Susan G. Komen Breast Cancer Foundation

The Susan G. Komen Breast Cancer Foundation was established in 1982 by Nancy Brinker to honor the memory of her sister, Susan G. Komen, who died from breast cancer at the age of 36. Today, the Foundation is an international organization with a network of more than 75,000 volunteers working through local Affiliates and events like the Komen Race for the Cure® to eradicate breast cancer as a life-threatening disease. A global leader in the fight against breast cancer, the Foundation fulfills its mission through support of innovative breast cancer research grants, meritorious awards and educational, scientific and community outreach programs around the world. Through fiscal year 2005, the Komen Foundation, together with its Affiliate Network, corporate partners and generous donors, has invested a projected $775 million in breast cancer research, education, screening and treatment programs. For questions about breast health or breast cancer, visit the Komen Foundation's Web site at www.komen.org or call the Komen Foundation's National Toll-Free Breast Care Helpline at 1.800.I'M AWARE® (1.800.462.9273).

About AstraZeneca

AstraZeneca is a major international healthcare business engaged in the research, development, manufacture and marketing of prescription pharmaceuticals and the supply of healthcare services. It is one of the world’s leading pharmaceutical companies with healthcare sales of over $21.4 billion and leading positions in sales of gastrointestinal, cardiovascular, respiratory, oncology and neuroscience products. AstraZeneca is listed in the Dow Jones Sustainability Index (Global) as well as the FTSE4Good Index. Worldwide, AstraZeneca has six major research and development sites, four discovery facilities and a clinical research site. In total, AstraZeneca’s R&D organization is comprised of more 11,500 people located in seven countries including Canada, France, India, Japan, Sweden, United Kingdom and the United States.